BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25022659)

  • 21. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
    Ni RM; Mo Y; Chen X; Zhong J; Liu W; Yang D
    Eur J Endocrinol; 2009 Sep; 161(3):411-8. PubMed ID: 19542239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is ovarian volume a good predictor to determine metabolic syndrome development in polycystic ovary patients.
    Sipahi M; Tokgöz VY; Keskin Ö; Atasever M; Menteşe A; Demir S
    J Obstet Gynaecol; 2019 Apr; 39(3):372-376. PubMed ID: 30744441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals.
    Mueller A; Gooren LJ; Naton-Schötz S; Cupisti S; Beckmann MW; Dittrich R
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1408-11. PubMed ID: 18211977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome].
    Rehme MF; Pontes AG; Corrente JE; Franco JG; Pontes A
    Rev Bras Ginecol Obstet; 2013 Dec; 35(12):562-8. PubMed ID: 24500511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hirsutism and Polycystic Ovarian Morphology are the Most Frequent Components of Polycystic Ovary Syndrome in Women with Type 1 Diabetes.
    García-Sáenz MR; Lobaton-Ginsberg M; Ramírez-Rentería C; López-Juárez N; Saucedo R; Valencia-Ortega J; Ferreira-Hermosillo A
    Arch Med Res; 2023 Nov; 54(7):102895. PubMed ID: 37866088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
    Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyslipidemia involvement in the development of polycystic ovary syndrome.
    Liu Q; Xie YJ; Qu LH; Zhang MX; Mo ZC
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):447-453. PubMed ID: 31307731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis.
    Yang R; Yang S; Li R; Liu P; Qiao J; Zhang Y
    Reprod Biol Endocrinol; 2016 Oct; 14(1):67. PubMed ID: 27756332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of the free androgen index depends on the phenotype of polycystic ovary syndrome - a single-centre experience.
    Ożga K; Krzyczkowska-Sendrakowska M; Hubalewska-Dydejczyk A; Gilis-Januszewska A; Ratajczak M; Ratajczak M; Chaykivska Z; Jach R
    Endokrynol Pol; 2019; 70(4):330-335. PubMed ID: 30938834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome.
    Jędrzejuk D; Laczmański L; Kuliczkowska J; Lenarcik A; Trzmiel-Bira A; Hirnle L; Dorobisz U; Milewicz A; Lwow F; Urbanovych A; Słoka N
    Gynecol Endocrinol; 2015 Jan; 31(1):36-9. PubMed ID: 25093427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neck circumference is independently associated with metabolic syndrome in women with polycystic ovary syndrome.
    Liu C; Ding L; Yang H; Chen Z
    Endocr J; 2022 Jul; 69(7):809-818. PubMed ID: 35173107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.
    Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K
    Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance.
    Cupisti S; Häberle L; Dittrich R; Oppelt PG; Reissmann C; Kronawitter D; Beckmann MW; Mueller A
    Fertil Steril; 2010 Jul; 94(2):673-7. PubMed ID: 19394003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.
    Mehrabian F; Khani B; Kelishadi R; Kermani N
    J Res Med Sci; 2011 Jun; 16(6):763-9. PubMed ID: 22091305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
    Rosenfield RL; Ehrmann DA
    Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
    Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
    Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
    Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.